FTY720, a synthetic sphingosine 1-phosphate (S1P) analogue, inhibits development of atherosclerosis in LDL receptor-deficient mice

被引:0
|
作者
Nofer, Jerzy Roch
Martine, Bot
Martin, Brodde
van Berkel, Theo J.
Assmann, Gerd
Biessen, Erik A.
机构
[1] Univ Munster, Munster, Germany
[2] Leiden Univ, Leiden, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:293 / 293
页数:1
相关论文
共 50 条
  • [1] FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice
    Nofer, Jerzy-Roch
    Bot, Martine
    Brodde, Martin
    Taylor, Paul J.
    Salm, Paul
    Brinkmann, Volker
    van Berkel, Theo
    Assmann, Gerd
    Biessen, Erik A. L.
    CIRCULATION, 2007, 115 (04) : 501 - 508
  • [2] Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R-/-) mice
    Poti, Francesco
    Costa, Sara
    Bergonzini, Valeria
    Galletti, Margherita
    Pignatti, Elisa
    Weber, Christian
    Simoni, Manuela
    Nofer, Jerzy-Roch
    VASCULAR PHARMACOLOGY, 2012, 57 (01) : 56 - 64
  • [3] Sphingosine 1-phosphate receptor 1 signaling in macrophages reduces atherosclerosis in LDL receptor-deficient mice
    Poti, Francesco
    Scalera, Enrica
    Feuerborn, Renata
    Fischer, Josephine
    Arndt, Lilli
    Varga, Georg
    Pardali, Evangelia
    Seidl, Matthias D.
    Fobker, Manfred
    Liebisch, Gerhard
    Hesse, Bettina
    Lukasz, Alexander H.
    Rossaint, Jan
    Kehrel, Beate E.
    Rosenbauer, Frank
    Renne, Thomas
    Christoffersen, Christina
    Simoni, Manuela
    Burkhardt, Ralph
    Nofer, Jerzy-Roch
    JCI INSIGHT, 2024, 9 (24)
  • [4] The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in Apolipoprotein E-deficient mice
    Keul, P.
    Toelle, M.
    Lucke, S.
    Lipinski, K. Von Wnuck
    Heusch, G.
    Schuchardt, M.
    Van der Giet, M.
    Levkau, B.
    EUROPEAN HEART JOURNAL, 2007, 28 : 796 - 797
  • [5] The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1
    Schmid, Gerald
    Guba, Markus
    Ischenko, Ivan
    Papyan, Armine
    Loka, Mareile
    Schrepfer, Sabine
    Bruns, Christiane J.
    Jauch, Karl-Walter
    Heeschen, Christopher
    Graeb, Christian
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 101 (01) : 259 - 270
  • [6] The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice
    Keul, Petra
    Toelle, Markus
    Lucke, Susann
    Lipinski, Karin von Wnuck
    Heusch, Gerd
    Schuchardt, Mirjam
    van der Giet, Markus
    Levkau, Bodo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) : 607 - 613
  • [7] The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein e-deficient mice
    Keul, Petra
    Toelle, Markus
    Lucke, Susann
    von Wnuck Lipinski, Karin
    Heusch, Gerd
    Schuchardt, Mirjam
    van der Giet, Markus
    Levkau, Bodo
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S224 - S224
  • [8] The sphingosine 1-phosphate analogue, FTY720, modulates the lipidomic signature of the mouse hippocampus
    Magalhaes, Daniela M.
    Stewart, Nicolas A.
    Mampay, Myrthe
    Rolle, Sara O.
    Hall, Chloe M.
    Moeendarbary, Emad
    Flint, Melanie S.
    Sebastiao, Ana M.
    Valente, Claudia A.
    Dymond, Marcus K.
    Sheridan, Graham K.
    JOURNAL OF NEUROCHEMISTRY, 2024, 168 (06) : 1113 - 1142
  • [9] FTY720 Story: Discovery of the First SPhingosine 1-Phosphate Receptor Modulator
    Adachi, Kunitomo
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2011, 69 (08) : 904 - 912